NCT04276298View on ClinicalTrials.gov

Topical Analgesia Post-Haemorrhoidectomy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Hemorrhoid PainHemorrhoids
Interventions
DRUG

Metronidazole cream

10% metronidazole applied rectally

DRUG

Metronidazole and Diltiazem cream

Combination Metronidazole and Diltiazem applied rectally

DRUG

Metronidazole and Lidocaine cream

Combination metronidazole and lignocaine applied rectally

DRUG

Metronidazole, Diltiazem and Lidocaine cream

Combination of all active agents tested applied rectally

Trial Locations (1)

1041

Counties Manukau District Health Board, Auckland

All Listed Sponsors
lead

University of Auckland, New Zealand

OTHER

NCT04276298 - Topical Analgesia Post-Haemorrhoidectomy | Biotech Hunter | Biotech Hunter